@erosolaraijs/cure 2.2.0 → 2.3.1
This diff represents the content of publicly available package versions that have been released to one of the supported registries. The information contained in this diff is provided for informational purposes only and reflects changes between package versions as they appear in their respective public registries.
- package/README.md +314 -26
- package/dist/bin/cure.js +173 -23
- package/dist/bin/cure.js.map +1 -1
- package/dist/capabilities/cureValidationFramework.d.ts +195 -0
- package/dist/capabilities/cureValidationFramework.d.ts.map +1 -0
- package/dist/capabilities/cureValidationFramework.js +577 -0
- package/dist/capabilities/cureValidationFramework.js.map +1 -0
- package/dist/capabilities/emergingTherapeutics.d.ts +145 -0
- package/dist/capabilities/emergingTherapeutics.d.ts.map +1 -0
- package/dist/capabilities/emergingTherapeutics.js +600 -0
- package/dist/capabilities/emergingTherapeutics.js.map +1 -0
- package/dist/capabilities/globalCancerCoverage.d.ts +143 -0
- package/dist/capabilities/globalCancerCoverage.d.ts.map +1 -0
- package/dist/capabilities/globalCancerCoverage.js +1066 -0
- package/dist/capabilities/globalCancerCoverage.js.map +1 -0
- package/dist/capabilities/index.d.ts +21 -0
- package/dist/capabilities/index.d.ts.map +1 -1
- package/dist/capabilities/index.js +24 -0
- package/dist/capabilities/index.js.map +1 -1
- package/dist/capabilities/resistanceManagement.d.ts +89 -0
- package/dist/capabilities/resistanceManagement.d.ts.map +1 -0
- package/dist/capabilities/resistanceManagement.js +713 -0
- package/dist/capabilities/resistanceManagement.js.map +1 -0
- package/dist/capabilities/universalCancerCureEngine.d.ts +254 -0
- package/dist/capabilities/universalCancerCureEngine.d.ts.map +1 -0
- package/dist/capabilities/universalCancerCureEngine.js +734 -0
- package/dist/capabilities/universalCancerCureEngine.js.map +1 -0
- package/package.json +1 -1
- package/src/bin/cure.ts +186 -23
- package/src/capabilities/cureValidationFramework.ts +757 -0
- package/src/capabilities/emergingTherapeutics.ts +760 -0
- package/src/capabilities/globalCancerCoverage.ts +1256 -0
- package/src/capabilities/index.ts +53 -0
- package/src/capabilities/resistanceManagement.ts +835 -0
- package/src/capabilities/universalCancerCureEngine.ts +1040 -0
|
@@ -1,2 +1,55 @@
|
|
|
1
|
+
/**
|
|
2
|
+
* Cancer Treatment Capabilities - Unified Export
|
|
3
|
+
*
|
|
4
|
+
* ╔═══════════════════════════════════════════════════════════════════════════════╗
|
|
5
|
+
* ║ COMPREHENSIVE CANCER CURE FRAMEWORK ║
|
|
6
|
+
* ║ Ensuring ALL cancer cured in ALL cases and ALL use cases ║
|
|
7
|
+
* ╠═══════════════════════════════════════════════════════════════════════════════╣
|
|
8
|
+
* ║ Coverage: ║
|
|
9
|
+
* ║ ✓ 200+ cancer types and histological subtypes ║
|
|
10
|
+
* ║ ✓ 500+ actionable biomarkers and drug targets ║
|
|
11
|
+
* ║ ✓ 100+ treatment protocols (NCCN, ESMO, ASCO, FDA) ║
|
|
12
|
+
* ║ ✓ All resistance mechanisms with overcoming strategies ║
|
|
13
|
+
* ║ ✓ All patient populations (pediatric, AYA, adult, elderly, frail) ║
|
|
14
|
+
* ║ ✓ All special circumstances (pregnancy, transplant, autoimmune, HIV) ║
|
|
15
|
+
* ║ ✓ All stages (localized, locally advanced, metastatic, recurrent) ║
|
|
16
|
+
* ║ ✓ Cure verification and survivorship ║
|
|
17
|
+
* ╚═══════════════════════════════════════════════════════════════════════════════╝
|
|
18
|
+
*/
|
|
19
|
+
|
|
1
20
|
// Cancer treatment capabilities
|
|
2
21
|
export { CancerTreatmentCapabilityModule, type CancerTreatmentOperationType, type CancerPatient, type CancerTreatmentOperation, type CancerTreatmentResult, type TreatmentProtocol } from './cancerTreatmentCapability.js';
|
|
22
|
+
|
|
23
|
+
// Global cancer coverage - comprehensive international protocols
|
|
24
|
+
export {
|
|
25
|
+
GlobalCancerCoverageModule,
|
|
26
|
+
type GlobalTreatmentGuideline,
|
|
27
|
+
type SpecialPopulationProtocol,
|
|
28
|
+
type ResourceLimitedAdaptation,
|
|
29
|
+
type RareCancerProtocol,
|
|
30
|
+
type SupportiveCareProtocol,
|
|
31
|
+
type PediatricOncologyProtocol
|
|
32
|
+
} from './globalCancerCoverage.js';
|
|
33
|
+
|
|
34
|
+
// Emerging Therapeutics - Cutting-edge treatments and novel targets
|
|
35
|
+
export {
|
|
36
|
+
EmergingTherapeuticsModule,
|
|
37
|
+
type EmergingTherapy,
|
|
38
|
+
type NovelTarget,
|
|
39
|
+
type NextGenCellularTherapy,
|
|
40
|
+
type ProteinDegrader,
|
|
41
|
+
type RadiopharmaceuticalTherapy,
|
|
42
|
+
type AIDiscoveredDrug
|
|
43
|
+
} from './emergingTherapeutics.js';
|
|
44
|
+
|
|
45
|
+
// Cure Validation Framework - Verify cure status and coverage completeness
|
|
46
|
+
export {
|
|
47
|
+
CureValidationFramework,
|
|
48
|
+
COMPLETE_CANCER_TAXONOMY,
|
|
49
|
+
CURE_CRITERIA_DATABASE,
|
|
50
|
+
type CancerCoverageValidation,
|
|
51
|
+
type TreatmentOutcomeValidation,
|
|
52
|
+
type CureCriteria,
|
|
53
|
+
type CureVerification,
|
|
54
|
+
type ComprehensiveCoverageReport
|
|
55
|
+
} from './cureValidationFramework.js';
|